MedPath

Effect of Adding Sina Curcumin to Sertraline in Treatment of Depressio

Phase 3
Conditions
Major Depressive Disorder.
Major depressive disorder, single episode, severe without psychotic features
Registration Number
IRCT20101130005280N26
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Having diagnostic criteria for Major Depressive Disorder
Aged between 18-50 years
Written consent form

Exclusion Criteria

History of suicide or having suicidal thoughts
Psychosis
Substance abuse
Taking other drugs
Neurological diseases
History of head trauma
Creating side effects

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression. Timepoint: Baseline, 4th WEEK, 8th week. Method of measurement: Beck Depression Inventory.;Anxiety. Timepoint: Baseline, 4th WEEK, 8th week. Method of measurement: Beck Anxiety Inventory.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: 4th week, 8th week. Method of measurement: Side Effects Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath